SC 13G/A 1 k60033sc13ga.txt AMENDMENT #2 TO SCHEDULE 13G 1 SCHEDULE 13G/A (RULE 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Rockwell Medical Technologies, Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Shares, no par value per share -------------------------------------------------------------------------------- (Title of Class of Securities) 774374 10 2 -------------------------------------------------------------------------------- (CUSIP Number) January 26, 1998 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 pages 2 CUSIP NO. 774374 10 2 13G/A PAGE 2 OF 7 PAGES -------------------------------------------------------------------------------- 1 Names of Reporting Persons/I.R.S. Identification Nos. of Above Persons (Entities Only) Gary D. Lewis -------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (a) [ ] (See Instructions) (b) [x] -------------------------------------------------------------------------------- 3 SEC Use Only -------------------------------------------------------------------------------- 4 Citizenship or Place of Organization United States of America -------------------------------------------------------------------------------- Number of 5 Sole Voting Power Shares 30,000 ----------------------------------------------------- Beneficially 6 Shared Voting Power 513,900* Owned by ----------------------------------------------------- 7 Sole Dispositive Power Each 30,000 ----------------------------------------------------- Reporting 8 Shared Dispositive Power Person With 513,900* -------------------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person 543,900 -------------------------------------------------------------------------------- 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ] (See Instructions) -------------------------------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (9) 11.1% -------------------------------------------------------------------------------- 12 Type of Reporting Person (See Instructions) IN -------------------------------------------------------------------------------- * These shares are owned jointly with Catherine G. Lewis. 3 CUSIP NO. 774374 10 2 13G/A PAGE 3 OF 7 PAGES -------------------------------------------------------------------------------- 1 Names of Reporting Persons/I.R.S. Identification Nos. of Above Persons (Entities Only) Catherine G. Lewis -------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (a) [ ] (See Instructions) (b) [x] -------------------------------------------------------------------------------- 3 SEC Use Only -------------------------------------------------------------------------------- 4 Citizenship or Place of Organization United States of America -------------------------------------------------------------------------------- Number of 5 Sole Voting Power Shares ----------------------------------------------------- Beneficially 6 Shared Voting Power 513,900* Owned by ----------------------------------------------------- 7 Sole Dispositive Power Each ----------------------------------------------------- Reporting 8 Shared Dispositive Power Person With 513,900* -------------------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person 513,900 -------------------------------------------------------------------------------- 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ] (See Instructions) -------------------------------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (9) 10.6% -------------------------------------------------------------------------------- 12 Type of Reporting Person (See Instructions) IN -------------------------------------------------------------------------------- * These shares are owned jointly with Gary D. Lewis. 4 CUSIP No. 774374 10 2 ITEM 1. (a) Name of Issuer: Rockwell Medical Technologies, Inc. (b) Address of Issuer's Principal Executive Offices: 28025 Oakland Oaks Drive Wixom, Michigan 48393 ITEM 2. (a) Name of Person Filing: Gary D. Lewis Catherine G. Lewis (b) Address of Principal Business Office or, if none, Residence: Both P.O. Box 36940 Grosse Pointe, Michigan 48236 (c) Citizenship: Both United States of America (d) Title of Class of Securities: Common Shares, no par value per share (e) CUSIP Number: 774374 10 2 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.SS.240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE FILING PERSON IS A: Not Applicable ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Page 4 of 7 pages 5 CUSIP No. 774374 10 2 (a) Amount beneficially owned: Gary D. Lewis 543,900*/** Catherine G. Lewis 513,900** (b) Percent of class: Gary D. Lewis 11.1% Catherine G. Lewis 10.6% (c) Number of Shares as to which the person has: (i) Sole power to vote or to direct the vote: Gary D. Lewis 30,000* Catherine G. Lewis 0 (ii) Shared power to vote or direct the vote: Gary D. Lewis 513,900** Catherine G. Lewis 513,900** (iii) Sole power to dispose or to direct the disposition of: Gary D. Lewis 30,000* Catherine G. Lewis 0 (iv) Shared power to dispose or to direct the disposition of: Gary D. Lewis 513,900** Catherine G. Lewis 513,900** * 30,000 of these shares are shares that Gary D. Lewis may acquire upon exercise of options granted to him by Rockwell Medical Technologies, Inc. ** 513,900 of these shares are jointly owned by Catherine G. Lewis and Gary D. Lewis. 25,000 of these shares are owned by Maria M. Lewis a minor child of Catherine G. Lewis and Gary D. Lewis for whom Catherine G. Lewis and Gary D. Lewis share dispositive and voting power as custodians. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following | |. Page 5 of 7 pages 6 CUSIP No. 774374 10 2 ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATION. Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 9, 2001 /s/ Gary D. Lewis --------------------------- Gary D. Lewis Dated: February 9, 2001 /s/ Catherine G. Lewis --------------------------- Catherine G. Lewis Page 6 of 7 pages 7 CUSIP No. 774374 10 2 Exhibit 1 JOINT STATEMENT AGREEMENT The undersigned hereby agree that the Schedule 13G/A filed by them with respect to their beneficial ownership of Rockwell Medical Technology, Inc. Common Shares as of December 31, 2000 shall be filed on behalf of each of them. Dated: February 9, 2001 /s/ Gary D. Lewis --------------------------- Gary D. Lewis Dated: February 9, 2001 /s/ Catherine G. Lewis --------------------------- Catherine G. Lewis Page 7 of 7 pages